HCWB HCW Biologics Inc.
Healthcare$2.89+12.02%ClosedMarket Cap: $6.0M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
1.05
P/S
0.91
EV/EBITDA
-10.78
DCF Value
$-7.80
FCF Yield
-190.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
99.2%
Operating Margin
-97.9%
Net Margin
-24.7%
ROE
-102.4%
ROA
-6.0%
ROIC
-38.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $6.5M | 99.8% | $3.2M | $4.1M | $— | — |
| Q4 null | $27.0K | 20.0% | $-2.9M | $719.2K | $— | — |
| FY null | $54.2K | 20.0% | $-11.3M | $-8.0M | $— | — |
| Q3 null | $15.6K | 20.0% | $-3.3M | $-4.6M | $— | — |
| Q2 null | $6.5K | 20.0% | $-3.5M | $-1.9M | $— | — |
| Q1 null | $5.1K | 20.0% | $-2.0M | $-2.2M | $— | — |
| Q4 null | $394.8K | 20.0% | $-3.2M | $-3.4M | $— | — |
| FY null | $2.6M | 37.4% | $-29.5M | $-30.0M | $— | — |
| Q3 null | $426.4K | 20.0% | $-3.7M | $-3.9M | $— | — |
| Q2 null | $618.9K | 29.2% | $-15.1M | $-15.3M | $— | — |
| Q1 null | $1.1M | 54.6% | $-7.5M | $-7.5M | $— | — |
| Q4 2023 | $1.3M | -377.4% | $-10.8M | $-10.7M | $-0.30 | — |